Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 10
Submit an article Journal homepage
229
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia

Matthew J. Reesa Department of Clinical Haematology, Austin Health, Melbourne, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8360-2952
ORCID Icon,
Simon Wub Department of Clinical Haematology, Eastern Health, Melbourne, Australia
,
Mridula Mokoonlallc Department of Clinical Haematology, Canberra Hospital, Canberra, Australia
,
Caroline H. K. Dixd Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia
,
Christian E. Bryantd Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia
,
James D’Rozarioc Department of Clinical Haematology, Canberra Hospital, Canberra, Australia
,
Anthony Schwarera Department of Clinical Haematology, Austin Health, Melbourne, Australia;b Department of Clinical Haematology, Eastern Health, Melbourne, Australia
,
Andrew Grigga Department of Clinical Haematology, Austin Health, Melbourne, Australia
&
Ing Soo Tionga Department of Clinical Haematology, Austin Health, Melbourne, Australia
 show all
Pages 2531-2534 | Received 17 Feb 2021, Accepted 07 Apr 2021, Published online: 26 Apr 2021

References

  • Aldoss I, Douer D. How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia. Blood. 2020;135(13):987–995.
  • Patel B, Kirkwood AA, Dey A, et al. Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial. Leukemia. 2017;31(1):58–64.
  • Toft N, Birgens H, Abrahamsson J, et al. Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia. Leukemia. 2018;32(3):606–615.
  • Huguet F, Leguay T, Raffoux E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol. 2009;27(6):911–918.
  • Huguet F, Chevret S, Leguay T, et al.; for the Group of Research on Adult ALL (GRAALL). Intensified therapy of acute lymphoblastic leukemia in adults: Report of the randomized GRAALL-2005 clinical trial. J Clin Oncol. 2018;36(24):2514–2523.
  • Storring JM, Minden MD, Kao S, et al. Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen. Br J Haematol. 2009;146(1):76–85.
  • DeAngelo DJ, Stevenson KE, Dahlberg SE, et al. Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia. Leukemia. 2015;29(3):526–534.
  • Douer D, Aldoss I, Lunning MA, et al. Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia. J Clin Oncol. 2014;32(9):905–911.
  • Park J, Ritchie E, Rao A, et al. A pediatric-inspired regimen containing multiple doses of intravenous pegylated asparaginase appears safe and effective in newly diagnosed adult patients with Ph-negative acute lymphoblastic leukemia in adults up to age 60: results of a multi-center phase II clinical trial. Blood. 2016;128(22):1629.
  • U.S. Department of health and human services NCI. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0.: National Institute of Health; 2017. [cited 2020]. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf
  • Daley RJ, Rajeeve S, Kabel CC, et al. Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia. Leuk Lymphoma. 2020;28(24):1–9.
  • Thomas DA, O'Brien S, Faderl S, et al. Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia. J Clin Oncol. 2010;28(24):3880–3889.
  • Orvain C, Balsat M, Tavernier E, et al. Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study. Blood. 2020;136(3):328–338.
  • Freyer CW, Carulli A, Ganetsky A, et al. Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation. Leuk Lymphoma. 2020;61(9):2200–2207.
  • Kantarjian H, Thomas D, O'Brien S, et al. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004;101(12):2788–2801.
  • Ramanujachar R, Richards S, Hann I, et al. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer. 2007;48(3):254–261.
  • Advani AS, Larsen E, Laumann K, et al. Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia. Blood Advances. 2021;5(2):504–512.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.